{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:42:36Z","timestamp":1765802556334,"version":"3.48.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic Research Project of the Yunnan Provincial Department of Science and Technology","award":["(202301AY070001-136)"],"award-info":[{"award-number":["(202301AY070001-136)"]}]},{"name":"the Yunnan Province Youth Talent Project","award":["dqb2020008"],"award-info":[{"award-number":["dqb2020008"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460065"],"award-info":[{"award-number":["82460065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Yunnan Fundamental Research Kunming Medical University Projects","award":["202501AY070001-244"],"award-info":[{"award-number":["202501AY070001-244"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"DOI":"10.1007\/s00392-025-02823-0","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:37:34Z","timestamp":1765802254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of clonal hematopoiesis of indeterminate potential on prognosis in patients with severe aortic valve stenosis: a meta-analysis"],"prefix":"10.1007","author":[{"given":"Huang","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2823_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1182\/asheducation-2018.1.264","volume":"2018","author":"DP Steensma","year":"2018","unstructured":"Steensma DP (2018) Clinical consequences of clonal hematopoiesis of indeterminate potential. Hematology Am Soc Hematol Educ Program 2018:264\u2013269. https:\/\/doi.org\/10.1182\/asheducation-2018.1.264","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2823_CR2","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood.2023022222","volume":"2023","author":"LD Weeks","year":"2023","unstructured":"Weeks LD, Ebert BL (2023) Causes and consequences of clonal hematopoiesis. Blood 2023:2235\u20132246. https:\/\/doi.org\/10.1182\/blood.2023022222","journal-title":"Blood"},{"key":"2823_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.aay9333","volume":"2020","author":"CJ Watson","year":"2020","unstructured":"Watson CJ et al (2020) The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science 2020:1449\u20131454. https:\/\/doi.org\/10.1126\/science.aay9333","journal-title":"Science"},{"key":"2823_CR4","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"2014","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S et al (2014) Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 2014:2488\u20132498. https:\/\/doi.org\/10.1056\/NEJMoa1408617","journal-title":"N Engl J Med"},{"key":"2823_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","volume":"2017","author":"M Buscarlet","year":"2017","unstructured":"Buscarlet M et al (2017) DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood 2017:753\u2013762. https:\/\/doi.org\/10.1182\/blood-2017-04-777029","journal-title":"Blood"},{"key":"2823_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL (2019) Clonal hematopoiesis in human aging and disease. Science. https:\/\/doi.org\/10.1126\/science.aan4673","journal-title":"Science"},{"key":"2823_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","volume":"2020","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S, Libby P (2020) Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol 2020:137\u2013144. https:\/\/doi.org\/10.1038\/s41569-019-0247-5","journal-title":"Nat Rev Cardiol"},{"key":"2823_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","volume":"2018","author":"M Buscarlet","year":"2018","unstructured":"Buscarlet M et al (2018) Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A. Blood 2018:277\u2013280. https:\/\/doi.org\/10.1182\/blood-2018-01-829937","journal-title":"Blood"},{"key":"2823_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.03.401","author":"ED Gumuser","year":"2023","unstructured":"Gumuser ED et al (2023) Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.401","journal-title":"J Am Coll Cardiol"},{"key":"2823_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ajh.26465","volume":"2022","author":"MK Nowakowska","year":"2022","unstructured":"Nowakowska MK et al (2022) Association of clonal hematopoiesis mutations with clinical outcomes: a systematic review and meta-analysis. Am J Hematol 2022:411\u2013420. https:\/\/doi.org\/10.1002\/ajh.26465","journal-title":"Am J Hematol"},{"key":"2823_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"2017","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S et al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 2017:111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1701719","journal-title":"N Engl J Med"},{"key":"2823_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.065597","author":"AE Lin","year":"2024","unstructured":"Lin AE et al (2024) Clonal hematopoiesis of indeterminate potential with loss of Tet2 enhances risk for atrial fibrillation through Nlrp3 inflammasome activation. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.123.065597","journal-title":"Circulation"},{"key":"2823_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jamacardio.2024.0459","volume":"2024","author":"S Saadatagah","year":"2024","unstructured":"Saadatagah S et al (2024) Atrial fibrillation and clonal hematopoiesis in TET2 and ASXL1. JAMA Cardiol 2024:497\u2013506. https:\/\/doi.org\/10.1001\/jamacardio.2024.0459","journal-title":"JAMA Cardiol"},{"key":"2823_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.53244","author":"A Schuermans","year":"2024","unstructured":"Schuermans A et al (2024) Clonal hematopoiesis and incident heart failure with preserved ejection fraction. JAMA Netw Open. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.53244","journal-title":"JAMA Netw Open"},{"key":"2823_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","volume":"2019","author":"L Dorsheimer","year":"2019","unstructured":"Dorsheimer L et al (2019) Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 2019:25\u201333. https:\/\/doi.org\/10.1001\/jamacardio.2018.3965","journal-title":"JAMA Cardiol"},{"key":"2823_CR16","doi-asserted-by":"publisher","first-page":"e035498","DOI":"10.1161\/jaha.124.035498","volume":"2024","author":"M Momoi","year":"2024","unstructured":"Momoi M et al (2024) Clonal hematopoiesis in chronic thromboembolic pulmonary hypertension. J Am Heart Assoc 2024:e035498. https:\/\/doi.org\/10.1161\/jaha.124.035498","journal-title":"J Am Heart Assoc"},{"key":"2823_CR17","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/ejhf.3408","volume":"2024","author":"FL Scolari","year":"2024","unstructured":"Scolari FL et al (2024) Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy. Eur J Heart Fail 2024:2193\u20132202. https:\/\/doi.org\/10.1002\/ejhf.3408","journal-title":"Eur J Heart Fail"},{"key":"2823_CR18","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","volume":"2013","author":"RL Osnabrugge","year":"2013","unstructured":"Osnabrugge RL et al (2013) Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013:1002\u20131012. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.015","journal-title":"J Am Coll Cardiol"},{"key":"2823_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2019.05.016","author":"AE Kostyunin","year":"2019","unstructured":"Kostyunin AE et al (2019) Development of calcific aortic valve disease: do we know enough for new clinical trials? J Mol Cell Cardiol. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.05.016","journal-title":"J Mol Cell Cardiol"},{"key":"2823_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac192","author":"A Trimaille","year":"2023","unstructured":"Trimaille A et al (2023) Aortic stenosis and the haemostatic system. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvac192","journal-title":"Cardiovasc Res"},{"key":"2823_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.amjcard.2023.08.067","volume":"2023","author":"M Yamamoto","year":"2023","unstructured":"Yamamoto M et al (2023) Predictors of all-cause mortality after successful transcatheter aortic valve implantation in patients with atrial fibrillation. Am J Cardiol 2023:150\u2013158. https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.067","journal-title":"Am J Cardiol"},{"key":"2823_CR22","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/cir.0000000000000932","volume":"2021","author":"CM Otto","year":"2021","unstructured":"Otto CM et al (2021) 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021:e35\u2013e71. https:\/\/doi.org\/10.1161\/cir.0000000000000932","journal-title":"Circulation"},{"key":"2823_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","volume":"2020","author":"S Mas-Peiro","year":"2020","unstructured":"Mas-Peiro S et al (2020) Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Eur Heart J 2020:933\u2013939. https:\/\/doi.org\/10.1093\/eurheartj\/ehz591","journal-title":"Eur Heart J"},{"key":"2823_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24130-8","volume":"2022","author":"F Vieceli Dalla Sega","year":"2022","unstructured":"Vieceli Dalla Sega F et al (2022) Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers. Sci Rep 2022:20400. https:\/\/doi.org\/10.1038\/s41598-022-24130-8","journal-title":"Sci Rep"},{"key":"2823_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00392-022-02135-7","volume":"2023","author":"S Mas-Peiro","year":"2023","unstructured":"Mas-Peiro S et al (2023) Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR. Clin Res Cardiol 2023:585\u2013593. https:\/\/doi.org\/10.1007\/s00392-022-02135-7","journal-title":"Clin Res Cardiol"},{"key":"2823_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.jacbts.2023.04.010","volume":"2023","author":"F Lassalle","year":"2023","unstructured":"Lassalle F et al (2023) Negative impact of TET2 mutations on long-term survival after transcatheter aortic valve replacement. JACC Basic Transl Sci 2023:1424\u20131435. https:\/\/doi.org\/10.1016\/j.jacbts.2023.04.010","journal-title":"JACC Basic Transl Sci"},{"key":"2823_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","volume":"2021","author":"CS Marnell","year":"2021","unstructured":"Marnell CS, Bick A, Natarajan P (2021) Clonal hematopoiesis of indeterminate potential (CHIP): linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J Mol Cell Cardiol 2021:98\u2013105. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.07.004","journal-title":"J Mol Cell Cardiol"},{"key":"2823_CR28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jacbts.2023.06.007","volume":"2023","author":"MA Evans","year":"2023","unstructured":"Evans MA, Walsh K (2023) Clonal hematopoiesis and transcatheter aortic valve replacement: a fatal connection. JACC Basic Transl Sci 2023:1436\u20131438. https:\/\/doi.org\/10.1016\/j.jacbts.2023.06.007","journal-title":"JACC Basic Transl Sci"},{"key":"2823_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.acvd.2021.01.002","volume":"2021","author":"S Fawaz","year":"2021","unstructured":"Fawaz S et al (2021) Clonal haematopoiesis and cardiovascular diseases: a growing relationship. Arch Cardiovasc Dis 2021:316\u2013324. https:\/\/doi.org\/10.1016\/j.acvd.2021.01.002","journal-title":"Arch Cardiovasc Dis"},{"key":"2823_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101532","volume":"2025","author":"CY Yao","year":"2025","unstructured":"Yao CY et al (2025) Clonal hematopoiesis is associated with adverse clinical outcomes and left ventricular remodeling in aortic stenosis. JACC Adv 2025:101532. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101532","journal-title":"JACC Adv"},{"key":"2823_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-025-02752-z","author":"JF Tierney","year":"2025","unstructured":"Tierney JF, Burdett S, Fisher DJ (2025) Practical methods for incorporating summary time-to-event data into meta-analysis: updated guidance. Syst Rev. https:\/\/doi.org\/10.1186\/s13643-025-02752-z","journal-title":"Syst Rev"},{"key":"2823_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/0145445516645763","author":"M Moeyaert","year":"2016","unstructured":"Moeyaert M, Maggin D, Verkuilen J (2016) Reliability, validity, and usability of data extraction programs for single-case research designs. Behav Modif. https:\/\/doi.org\/10.1177\/0145445516645763","journal-title":"Behav Modif"},{"key":"2823_CR33","doi-asserted-by":"publisher","unstructured":"Jamin RN et al (2025) Mutational landscape and impact of clonal hematopoiesis of indeterminate potential in severe aortic valve stenosis. Clin Res Cardiol 2025. https:\/\/doi.org\/10.1007\/s00392-025-02658-9","DOI":"10.1007\/s00392-025-02658-9"},{"key":"2823_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"2018","author":"S Sano","year":"2018","unstructured":"Sano S et al (2018) Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome. J Am Coll Cardiol 2018:875\u2013886. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.037","journal-title":"J Am Coll Cardiol"},{"key":"2823_CR35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"2017","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ et al (2017) Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 2017:842\u2013847. https:\/\/doi.org\/10.1126\/science.aag1381","journal-title":"Science"},{"key":"2823_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202577119","volume":"2022","author":"E The","year":"2022","unstructured":"The E et al (2022) Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3. Proc Natl Acad Sci U S A 2022:e2202577119. https:\/\/doi.org\/10.1073\/pnas.2202577119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2823_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2022.03.005","volume":"2022","author":"J Lu","year":"2022","unstructured":"Lu J et al (2022) Blocking the NLRP3 inflammasome reduces osteogenic calcification and M1 macrophage polarization in a mouse model of calcified aortic valve stenosis. Atherosclerosis 2022:28\u201338. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.03.005","journal-title":"Atherosclerosis"},{"key":"2823_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1321336","author":"T Stiehl","year":"2024","unstructured":"Stiehl T (2024) Stem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation - a virtual clinical trial. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1321336","journal-title":"Front Immunol"},{"key":"2823_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcm.2021.04.005","volume":"32","author":"NW Chavkin","year":"2022","unstructured":"Chavkin NW, Min KD, Walsh K (2022) Importance of clonal hematopoiesis in heart failure. Trends Cardiovasc Med 32:198\u2013203. https:\/\/doi.org\/10.1016\/j.tcm.2021.04.005","journal-title":"Trends Cardiovasc Med"},{"key":"2823_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/circresaha.120.317104","volume":"2021","author":"WT Abplanalp","year":"2021","unstructured":"Abplanalp WT et al (2021) Clonal hematopoiesis-driver DNMT3A mutations alter immune cells in heart failure. Circ Res 2021:216\u2013228. https:\/\/doi.org\/10.1161\/circresaha.120.317104","journal-title":"Circ Res"},{"key":"2823_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.05.010","author":"NA Jakobsen","year":"2024","unstructured":"Jakobsen NA et al (2024) Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging. Cell Stem Cell. https:\/\/doi.org\/10.1016\/j.stem.2024.05.010","journal-title":"Cell Stem Cell"},{"key":"2823_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1182\/blood.2023022260","volume":"2024","author":"W Liu","year":"2024","unstructured":"Liu W et al (2024) Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk. Blood 2024:1539\u20131550. https:\/\/doi.org\/10.1182\/blood.2023022260","journal-title":"Blood"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02823-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:37:36Z","timestamp":1765802256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02823-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":42,"alternative-id":["2823"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02823-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}